NL7713817A - Nieuwe, therapeutisch werkzame piperazinederiva- ten, werkwijzen ter bereiding hiervan en farma- ceutische preparaten die deze verbindingen be- vatten. - Google Patents

Nieuwe, therapeutisch werkzame piperazinederiva- ten, werkwijzen ter bereiding hiervan en farma- ceutische preparaten die deze verbindingen be- vatten.

Info

Publication number
NL7713817A
NL7713817A NL7713817A NL7713817A NL7713817A NL 7713817 A NL7713817 A NL 7713817A NL 7713817 A NL7713817 A NL 7713817A NL 7713817 A NL7713817 A NL 7713817A NL 7713817 A NL7713817 A NL 7713817A
Authority
NL
Netherlands
Prior art keywords
pharmacic
preparing
compounds
methods
same
Prior art date
Application number
NL7713817A
Other languages
English (en)
Dutch (nl)
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Publication of NL7713817A publication Critical patent/NL7713817A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7713817A 1976-12-14 1977-12-14 Nieuwe, therapeutisch werkzame piperazinederiva- ten, werkwijzen ter bereiding hiervan en farma- ceutische preparaten die deze verbindingen be- vatten. NL7713817A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB52223/76A GB1545094A (en) 1976-12-14 1976-12-14 Piperazine derivatives

Publications (1)

Publication Number Publication Date
NL7713817A true NL7713817A (nl) 1978-06-16

Family

ID=10463103

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7713817A NL7713817A (nl) 1976-12-14 1977-12-14 Nieuwe, therapeutisch werkzame piperazinederiva- ten, werkwijzen ter bereiding hiervan en farma- ceutische preparaten die deze verbindingen be- vatten.

Country Status (22)

Country Link
US (2) US4202896A (hr)
JP (1) JPS5382789A (hr)
AT (1) AT363090B (hr)
AU (1) AU516920B2 (hr)
BE (1) BE861853A (hr)
DE (1) DE2755752A1 (hr)
DK (1) DK147421C (hr)
ES (6) ES465047A1 (hr)
FI (1) FI69839C (hr)
GB (1) GB1545094A (hr)
HU (1) HU177999B (hr)
IE (1) IE46278B1 (hr)
IL (1) IL53597A0 (hr)
IT (1) IT1093045B (hr)
LU (1) LU78686A1 (hr)
NL (1) NL7713817A (hr)
NO (1) NO148150C (hr)
NZ (1) NZ185981A (hr)
PT (1) PT67400B (hr)
SE (1) SE435378B (hr)
YU (1) YU295877A (hr)
ZA (1) ZA777452B (hr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU546260B2 (en) * 1980-06-16 1985-08-22 Ferrosan A.B. Diphenylbutyl-1-acylpiperazines
NL8202636A (nl) * 1982-06-29 1984-01-16 Gist Brocades Nv Piperazinederivaten, werkwijzen ter bereiding daarvan en farmaceutische preparaten die deze verbindingen bevatten.
DE3600390A1 (de) * 1986-01-09 1987-07-16 Hoechst Ag Diarylalkyl-substituierte alkylamine, verfahren zu ihrer herstellung, ihre verwendung sowie sie enthaltende arzneimittel
US5162537A (en) * 1986-04-17 1992-11-10 Monsanto Company Benzhydryl compounds as herbicide antidotes
HU196194B (en) * 1986-04-28 1988-10-28 Richter Gedeon Vegyeszet Process for producing new 1-4 disubstituted piperazines and pharmaceuticals comprising the compounds
HU196195B (en) * 1986-04-28 1988-10-28 Richter Gedeon Vegyeszet Process for producing 1,4-disubstituted piperazine derivatives and pharmaceuticals comprising the compounds
HU196196B (en) * 1986-04-28 1988-10-28 Richter Gedeon Vegyeszet Process for producing new benzhydryl-piperazine derivatives and pharmaceuticals comprising the compounds
FR2601366B1 (fr) * 1986-07-10 1988-11-25 Andre Buzas Derives de la benzhydryloxyethyl-piperazine, procedes d'obtention et de compositions pharmaceutiques les contenant.
FR2636946B1 (fr) * 1988-09-23 1990-11-02 Lipha ((diarylmethoxy)alcoyl)-1 pyrrolidines et piperidines, procedes de preparation et medicaments les contenant
US5087627A (en) * 1989-03-15 1992-02-11 Santen Pharmaceutical Co., Ltd. Agent for treatment of disorders of the cerebro-neural transmission system
US5153198A (en) * 1989-03-15 1992-10-06 Santen Pharmaceutical Co., Ltd. Agent for treatment of disorders of the cerebro-neural transmission system
FR2661176B1 (fr) * 1990-04-20 1992-06-12 Adir Nouveau procede de preparation de la 1-(2,3,4-trimethoxybenzyl) piperazine en amination reductive.
DK178490D0 (da) * 1990-07-26 1990-07-26 Novo Nordisk As 1,4-disubstituerede piperaziner
US5276035A (en) * 1990-07-26 1994-01-04 Novo Nordisk A/S 1,4-disubstituted piperazines
WO1993000811A1 (en) * 1991-07-01 1993-01-21 The General Hospital Corporation Invertebrate phenylethanolamine transporter and the use thereof
JP3062249B2 (ja) * 1993-06-25 2000-07-10 ポーラ化成工業株式会社 ドーパミン再取込み阻害剤
DK1257541T3 (da) * 2000-01-11 2009-01-19 Molecular Insight Pharm Inc Farmakoforiske stoffer
US6743797B2 (en) * 2002-02-22 2004-06-01 Chantest, Inc. Methods for treating cardiac arrhythmia
US20050054010A1 (en) * 2003-07-15 2005-03-10 Brown Arthur M. High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins
US7211407B2 (en) * 2003-07-15 2007-05-01 Chan Test, Inc. High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins
US20050208595A1 (en) * 2004-03-19 2005-09-22 Brown Arthur M High throughput assay systems and methods for identifying agents that alter expression of cellular proteins
FR2884712B1 (fr) * 2005-04-21 2007-06-15 Oreal Compositions cosmetiques comprenant des derives de piperazine
EP2233470B1 (en) * 2005-07-04 2011-12-07 High Point Pharmaceuticals, LLC Histamine H3 receptor antagonists
JP2009537596A (ja) * 2006-05-23 2009-10-29 ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー ６−（４−シクロプロピルピペリジン−１−イル）−２’−メチル−［３，４’］−ビピリジン及びその医薬としての使用
SG163547A1 (en) * 2006-05-29 2010-08-30 High Point Pharmaceuticals Llc 3- (1, 3-benz0di0x0l-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist
EP2014656A3 (en) * 2007-06-11 2011-08-24 High Point Pharmaceuticals, LLC New heteocyclic h3 antagonists
US20120028992A1 (en) * 2010-08-02 2012-02-02 Brown Arthur M Pharmaceutical compositions for terminating acute episodes of cardiac arrhythmia, restoring sinus rhythm, preventing recurrence of cardiac arrhythmia and/or maintaining normal sinus rhythm in mammals
CN104529942B (zh) * 2014-12-10 2018-05-15 天津孚音生物科技发展有限公司 一种伐诺司林的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB837986A (en) 1956-07-10 1960-06-22 Henri Morren New piperazine derivatives and process for the preparation thereof
US2953568A (en) * 1958-03-03 1960-09-20 Ciba Pharm Prod Inc Derivatives of piperazine
CH410961A (de) * 1961-02-22 1966-04-15 Yoshitomi Pharmaceutical Verfahren zur Herstellung N-substituierter Piperazinderivate
DE1445692A1 (de) 1963-03-25 1969-03-20 Egyt Gyogyszervegyeszeti Gyar Verfahren zur Herstellung von Piperazinderivaten
DE1795375A1 (de) * 1968-09-21 1972-01-05 Boehringer Mannheim Gmbh Basische AEther und Verfahren zur Herstellung derselben
JPS504086A (hr) * 1973-01-18 1975-01-16

Also Published As

Publication number Publication date
IT1093045B (it) 1985-07-19
PT67400A (en) 1978-01-01
BE861853A (fr) 1978-06-14
DK147421C (da) 1985-02-11
US4265894A (en) 1981-05-05
ES465047A1 (es) 1979-01-01
ES473814A1 (es) 1979-04-16
NO148150B (no) 1983-05-09
GB1545094A (en) 1979-05-02
FI69839C (fi) 1986-05-26
ES473815A1 (es) 1979-05-01
IE46278L (en) 1978-06-14
DE2755752A1 (de) 1978-06-15
AU516920B2 (en) 1981-07-02
YU295877A (en) 1983-01-21
AU3157377A (en) 1979-06-21
ATA891177A (de) 1980-12-15
LU78686A1 (hr) 1978-04-17
DK557277A (da) 1978-06-15
ES473816A1 (es) 1979-04-16
SE7714184L (sv) 1978-06-15
AT363090B (de) 1981-07-10
IE46278B1 (en) 1983-04-20
FI69839B (fi) 1985-12-31
DK147421B (da) 1984-07-30
NO774307L (no) 1978-06-15
JPS5382789A (en) 1978-07-21
ES473817A1 (es) 1979-04-16
FI773786A (fi) 1978-06-15
US4202896A (en) 1980-05-13
IL53597A0 (en) 1978-03-10
NO148150C (no) 1983-08-24
PT67400B (en) 1979-05-21
ZA777452B (en) 1978-10-25
ES473818A1 (es) 1979-04-16
SE435378B (sv) 1984-09-24
HU177999B (en) 1982-02-27
NZ185981A (en) 1980-02-21
JPS6215546B2 (hr) 1987-04-08
DE2755752C2 (hr) 1991-12-05

Similar Documents

Publication Publication Date Title
NL7713817A (nl) Nieuwe, therapeutisch werkzame piperazinederiva- ten, werkwijzen ter bereiding hiervan en farma- ceutische preparaten die deze verbindingen be- vatten.
NL7704057A (nl) Werkwijze ter bereiding van nieuwe cefolosporine- derivaten, werkwijze ter bereiding van farmaceu- tische preparaten en gevormde farmaceutische preparaten.
NL7700861A (nl) Nieuwe cosmetische deodorantpreparaten.
NL7810520A (nl) Nieuwe 2,6-diaminonebularinen, alsmede farmaceutische preparaten die deze verbindingen bevatten.
NL7710502A (nl) Werkwijze ter bereiding van farmaceutische pre- paraten alsmede werkwijze ter bereiding van nieuwe, analgetisch werkzame verbindingen.
NL7704566A (nl) Werkwijze ter bereiding van nieuwe 1,2-dihydro- naftaleenderivaten, alsmede werkwijze ter bereiding van farmaceutische preparaten.
NL7614155A (nl) Niclosamide-suspensiepreparaten.
NL190848C (nl) 2alfa-cyaan-4alfa,5alfa-epoxy-3-oxo-androstaanverbindingen, alsmede preparaten die deze verbindingen bevatten.
NO148416C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-, morfolin- og tiazan-derivater
NL7803162A (nl) Nieuwe 1-aminoindaanderivaten, alsmede farmaceutische preparaten die deze bevatten.
NO151365C (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater.
NL7709853A (nl) Nieuwe farmaceutische toepassing van 4-carbamoyl- -5-hydroxyimidazol.
NO149428C (no) Fremgangsmaate for fremstilling av fysiologisk aktive prostaglandinderivater.
NL7708024A (nl) Gefixeerde haptoglobine-preparaten.
NL7803448A (nl) Nieuwe benzothiadiazinederivaten, alsmede farmaceutische preparaten die deze verbindingen bevatten.
NL7706742A (nl) Werkwijze ter bereiding van farmaceutische preparaten en werkwijze ter bereiding van nieuwe cefalosplrinederivaten.
NO147423C (no) Fremgangsmaate for fremstilling av 2-piperazinyl-kinazolinderivater.
NL7804907A (nl) Nieuwe chromeenderivaten, werkwijze ter bereiding daar- van en therapeutische preparaten.
NL7710646A (nl) Nieuwe pyridobenzodiazepinonen, werkwijze ter bereiding daarvan en van deze nieuwe verbin- dingen bevattende preparaten.
NL7500421A (nl) Nieuwe fenothiazinederivaten, alsmede de berei- ding daarvan en preparaten die de nieuwe feno- thiazinederivaten bevatten.
NL7710325A (nl) Werkwijze ter bereiding van nieuwe chinolinede- rivaten, alsmede werkwijze ter bereiding van farmaceutische preparaten.
NL7709477A (nl) Werkwijze ter bereiding van farmaceutische preparaten en werkwijze ter bereiding van nieuwe cefalosporine- derivaten.
NL7803253A (nl) Nieuwe dimere indool-dihydroindoolverbindingen, alsmede preparaten die deze verbindingen bevat- ten.
RO75739A (ro) Procedeu pentru prepararea unor carbamoil triazolil-o,n-acetali
NL7603307A (nl) Nieuwe heterocyclische verbindingen, de bereiding ervan en preparaten die deze verbindingen bevat- ten.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
A85 Still pending on 85-01-01
BB A search report has been drawn up
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: BROCADES-PHARMA B.V.

BV The patent application has lapsed